The technology used in the Nissei DM-3000, to measure blood pressure, is among the best rated for accuracy by Medaval Ltd. It has passed in clinical validation studies, between general and specific populations, according to recognised standard protocols, as published in peer-reviewed publications.
|Medaval||★★★ Recommendation||Recent clinical validation; recent protocol; multiple clinical validations|
|BIHS (UK and IRL)||Professional use||Published evidence|
|ESH (Europe)||Professional use||Published evidence|
|Japanese Society of Hypertension||Professional use (2019-2020)||No evidence provided|
|Stride BP||Office and hospital use for adults (Preferred)||Published evidence|
Tasker F, De Greeff A, Shennan AH. Development and validation of a blinded hybrid device according to the European Hypertension Society protocol: Nissei DM-3000. J Hum Hypertens. 2010 Sep;24(9):609-16. Epub: 2010 Jan 28. doi: 10.1038/jhh.2009.113. PMID: 20107491. Available from: www.nature.com.
ESH-IP:2002 - Pass General population
Stergiou GS, Karpettas N, Kollias A, Destounis A, Tzamouranis D. A perfect replacement for the mercury sphygmomanometer: the case of the hybrid blood pressure monitor. J Hum Hypertens. 2012 Apr;26(4):220-7. Epub: 2011 Sep 8. doi: 10.1038/jhh.2011.77. PMID: 21900952.
ESH-IP:2010 - Pass General population (Note: Modified protocol)